Cognito Therapeutics Investor
Cognito Therapeutics is a neurotechnology company that is developing disease-modifying treatments for CNS illnesses. Cognito Therapeutics raised $35 million for its neuro device aimed at treating Alzheimer's Therapeutics - ?
Headquarters:
United States
Industry:
Biotechnology, Heath and Wellness Technology
Technology:
Biotechnology, Heath and Wellness Technology
Employee Number:
53
Founded Date:
2016.0